Submission of Annual Report for the Financial Year 2024-25.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Global Longlife Hospital and Research Ltd has submitted its 14th Annual Report for FY 2024-25 to BSE, along with the notice for its 14th AGM scheduled for August 29, 2025 via video conferencing. Key financials show a sharp collapse in core operations: revenue from operations fell to ₹57.73 lakhs from ₹1,351.45 lakhs last year, a drop of nearly 96%. However, the company turned profitable with a PAT of ₹19.87 lakhs versus a loss of ₹218.81 lakhs in FY24, driven almost entirely by a surge in 'other income' to ₹501.61 lakhs (from ₹6.33 lakhs previously). EPS stood at ₹0.19 versus ₹(2.08) earlier. No dividend has been declared. The board saw changes with Ms. Hetal Thakkar appointed as Executive Director and Mr. Suresh Jani resigning as Chairman in October 2024. The registered office was also shifted to Sankalp Square, Ahmedabad, in October 2024.
Routine regulatory filing, but the financials raise serious concerns: the core hospital business has nearly dried up, and profitability depends on non-operating 'other income'. Shareholders should review the Annual Report carefully before the AGM on August 29, 2025 to understand the source of other income and the state of core operations.